Strategic Plans of Pfizer Case Study Example | Topics and Well Written Essays - 2000 words

Strategic Plans of Pfizer - Case Study Example Pfizer Inc. is one of the largest Pharmaceutical companies in the world with a huge range of products which are determinant in its success in controlling a major stake of the pharmaceutical industry. It has state-of-the-art research facilities across the world and does spend considerably in this field in pharmaceuticals. These facilities are constantly discovering and developing new quality products for the industry and are spread across over 150 countries and are striving to discover new market needs specific to each area or globally. Pfizer has four major divisions of businesses and they are the pharmaceutical sector, consumer healthcare, global R&D and the animal health sector and have within a short span been successful in creating a benchmark in these different groups and industries. In the pharmaceuticals industry, Pfizer's medicines are extensively used to treat cardiovascular or lipid lowering, infectious diseases, central nervous system disorders, arthritis, erectile dysfunction, allergies, diabetes, and women's health. In consumer healthcare sector, the company has leveraged its R&D advantage and has successfully created a niche for itself in over-the-counter medicines in the market. It realized the trend in the over-the-counter preferences of the consumers and developed the same and aggressively marketed the various products under different brands and is used for treating illnesses ranging from upper respiratory tract sicknesses to eye care. Apart from these over-the-counter products, Pfizer also is a l eader in providing high quality generic medicines for the consumers. Pfizer's global R& D is the largest in the pharmaceutical industry and is located in New London, CT. it has been successful in breakthrough R&D in the areas of depression, erectile dysfunction, high cholesterol, HIV infection, hypertension and systemic fungal infections along with the most intractable diseases like cancer, arthritis, osteoporosis and stroke. The company has also entered the animal healthcare and has four dedicated plants for making animal products. It is the leader in this market with vaccines, anti-parasites, anti-inflammatories, anti-infectives, medicines and new therapies for a range of problems and diseases in animals. The Competitive Intelligence Report would cover the four major market segments for research and analysis of the competition to Bayer AG which is also among the largest Pharmaceutical companies along with Pfizer Inc. A strategic plan will be charted out based on the findings in the report for these four major sectors particularly, the pharmaceuticals and consumer healthcare (www.pfizer.com, 2008). Data Collection - As on September 30, 2008, a total of 114 products were in the pipeline by Pfizer varying across 10 therapeutic areas which are Allergy and Respiration, Cardiovascular, metabolic and endocrine Diseases (CVMED), Gastrointestinal and Hepatology, Genitourinary/Sexual Health, Infectious Diseases, Inflammation, Neuroscience, Oncology, Ophthalmology and Pain . These are the result of new medicinal development efforts around the world and the products are in four various phases of